GlaxoSmithKline (GSK) Fails to deliver data

Key failure to deliver metrics for GlaxoSmithKline:

• Last SEC data release: 2024-12-13
• Last 15 days FTD volume: €0.67 M
• Last 3 months FTD volume: €57.9 M
• Last year FTD volume: €57.9 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for GlaxoSmithKline (GSK) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for GlaxoSmithKline (GSK) - since 2022

GlaxoSmithKline (GSK) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
AstraZeneca AZN	€55.82 M	€0.19 B	🇬🇧 UK
Pfizer PFE	€46.85 M	€0.35 B	🇺🇸 USA
Merck MRK	€26.45 M	€97.06 M	🇺🇸 USA
Novartis NVS	€81.73 M	€0.14 B	🇨🇭 Switzerland
Sanofi SNY	€5.87 M	€72.77 M	🇫🇷 France
Teva Pharmaceutical Industries TEVA	€14.49 M	€40.95 M	🇮🇱 Israel
Dynavax Technologies DVAX	€0.66 M	€32.36 M	🇺🇸 USA